BAXTER INTERNATIONAL INC (1BAX.MI) Fundamental Analysis & Valuation

BIT:1BAX • US0718131099

17.766 EUR
-13.14 (-42.51%)
Last: Feb 9, 2026, 07:00 PM

This 1BAX.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

Overall 1BAX gets a fundamental rating of 3 out of 10. We evaluated 1BAX against 65 industry peers in the Health Care Equipment & Supplies industry. 1BAX has a bad profitability rating. Also its financial health evaluation is rather negative. 1BAX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. 1BAX.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1BAX was profitable.
  • 1BAX had a positive operating cash flow in the past year.
  • In multiple years 1BAX reported negative net income over the last 5 years.
  • 1BAX had a positive operating cash flow in each of the past 5 years.
1BAX.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1.2 Ratios

  • The Return On Assets of 1BAX (-2.52%) is worse than 66.15% of its industry peers.
  • With a Return On Equity value of -9.32%, 1BAX is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
  • 1BAX has a Return On Invested Capital of 3.45%. This is in the lower half of the industry: 1BAX underperforms 64.62% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1BAX is significantly below the industry average of 10.72%.
  • The 3 year average ROIC (3.20%) for 1BAX is below the current ROIC(3.45%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.52%
ROE -9.32%
ROIC 3.45%
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
1BAX.MI Yearly ROA, ROE, ROIC1BAX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

  • 1BAX has a Operating Margin (7.67%) which is comparable to the rest of the industry.
  • 1BAX's Operating Margin has declined in the last couple of years.
  • 1BAX has a worse Gross Margin (38.01%) than 81.54% of its industry peers.
  • 1BAX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.67%
PM (TTM) N/A
GM 38.01%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
1BAX.MI Yearly Profit, Operating, Gross Margins1BAX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

2

2. 1BAX.MI Health Analysis

2.1 Basic Checks

  • 1BAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, 1BAX has more shares outstanding
  • Compared to 5 years ago, 1BAX has more shares outstanding
  • The debt/assets ratio for 1BAX is higher compared to a year ago.
1BAX.MI Yearly Shares Outstanding1BAX.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
1BAX.MI Yearly Total Debt VS Total Assets1BAX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

  • 1BAX has an Altman-Z score of 1.89. This is not the best score and indicates that 1BAX is in the grey zone with still only limited risk for bankruptcy at the moment.
  • 1BAX has a worse Altman-Z score (1.89) than 63.08% of its industry peers.
  • 1BAX has a debt to FCF ratio of 22.91. This is a negative value and a sign of low solvency as 1BAX would need 22.91 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 22.91, 1BAX is doing worse than 63.08% of the companies in the same industry.
  • A Debt/Equity ratio of 1.79 is on the high side and indicates that 1BAX has dependencies on debt financing.
  • 1BAX has a worse Debt to Equity ratio (1.79) than 81.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF 22.91
Altman-Z 1.89
ROIC/WACC0.49
WACC7.05%
1BAX.MI Yearly LT Debt VS Equity VS FCF1BAX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

  • 1BAX has a Current Ratio of 1.36. This is a normal value and indicates that 1BAX is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.36, 1BAX is in line with its industry, outperforming 44.62% of the companies in the same industry.
  • A Quick Ratio of 1.05 indicates that 1BAX should not have too much problems paying its short term obligations.
  • The Quick ratio of 1BAX (1.05) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 1.05
1BAX.MI Yearly Current Assets VS Current Liabilites1BAX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

3

3. 1BAX.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 0.37% over the past year.
  • 1BAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -4.21% yearly.
  • Looking at the last year, 1BAX shows a very negative growth in Revenue. The Revenue has decreased by -13.21% in the last year.
  • Measured over the past years, 1BAX shows a decrease in Revenue. The Revenue has been decreasing by -1.31% on average per year.
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%

3.2 Future

  • 1BAX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.87% yearly.
  • 1BAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.61% yearly.
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1BAX.MI Yearly Revenue VS Estimates1BAX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
1BAX.MI Yearly EPS VS Estimates1BAX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

6

4. 1BAX.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 7.79, which indicates a rather cheap valuation of 1BAX.
  • Based on the Price/Earnings ratio, 1BAX is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.45. 1BAX is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 8.38 indicates a reasonable valuation of 1BAX.
  • 1BAX's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BAX is cheaper than 95.38% of the companies in the same industry.
  • 1BAX is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.65, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.79
Fwd PE 8.38
1BAX.MI Price Earnings VS Forward Price Earnings1BAX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 81.54% of the companies in the same industry are more expensive than 1BAX, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, 1BAX is valued a bit cheaper than 80.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.86
EV/EBITDA 10.11
1BAX.MI Per share data1BAX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.96%
EPS Next 3Y3.75%

3

5. 1BAX.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.17%, 1BAX has a reasonable but not impressive dividend return.
  • 1BAX's Dividend Yield is a higher than the industry average which is at 1.01.
  • Compared to an average S&P500 Dividend Yield of 1.82, 1BAX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.17%

5.2 History

  • The dividend of 1BAX is nicely growing with an annual growth rate of 6.89%!
Dividend Growth(5Y)6.89%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • The earnings of 1BAX are negative and hence is the payout ratio. 1BAX will probably not be able to sustain this dividend level.
  • 1BAX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-90.91%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
1BAX.MI Yearly Income VS Free CF VS Dividend1BAX.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B

1BAX.MI Fundamentals: All Metrics, Ratios and Statistics

BAXTER INTERNATIONAL INC

BIT:1BAX (2/9/2026, 7:00:00 PM)

17.766

-13.14 (-42.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-20
Earnings (Next)04-24
Inst Owners97.07%
Inst Owner ChangeN/A
Ins Owners0.24%
Ins Owner ChangeN/A
Market Cap9.11B
Revenue(TTM)12.86B
Net Income(TTM)-649.00M
Analysts68.18
Price Target35.44 (99.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.17%
Yearly Dividend1.05
Dividend Growth(5Y)6.89%
DP-90.91%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.32%
Min EPS beat(2)1.94%
Max EPS beat(2)10.69%
EPS beat(4)4
Avg EPS beat(4)5.06%
Min EPS beat(4)1.64%
Max EPS beat(4)10.69%
EPS beat(8)7
Avg EPS beat(8)3.73%
EPS beat(12)8
Avg EPS beat(12)2.99%
EPS beat(16)12
Avg EPS beat(16)4.13%
Revenue beat(2)1
Avg Revenue beat(2)0.5%
Min Revenue beat(2)-0.93%
Max Revenue beat(2)1.93%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-0.93%
Max Revenue beat(4)1.93%
Revenue beat(8)4
Avg Revenue beat(8)-0.57%
Revenue beat(12)4
Avg Revenue beat(12)-1.99%
Revenue beat(16)5
Avg Revenue beat(16)-2.54%
PT rev (1m)-3.81%
PT rev (3m)-3.81%
EPS NQ rev (1m)-31.48%
EPS NQ rev (3m)-31.48%
EPS NY rev (1m)-22.05%
EPS NY rev (3m)-22.05%
Revenue NQ rev (1m)-30.35%
Revenue NQ rev (3m)-30.35%
Revenue NY rev (1m)-28.82%
Revenue NY rev (3m)-28.82%
Valuation
Industry RankSector Rank
PE 7.79
Fwd PE 8.38
P/S 0.84
P/FCF 18.86
P/OCF 10.61
P/B 1.55
P/tB N/A
EV/EBITDA 10.11
EPS(TTM)2.28
EY12.83%
EPS(NY)2.12
Fwd EY11.94%
FCF(TTM)0.94
FCFY5.3%
OCF(TTM)1.67
OCFY9.43%
SpS21.13
BVpS11.45
TBVpS-5.81
PEG (NY)N/A
PEG (5Y)N/A
Graham Number24.23
Profitability
Industry RankSector Rank
ROA -2.52%
ROE -9.32%
ROCE 5.12%
ROIC 3.45%
ROICexc 3.76%
ROICexgc 8.07%
OM 7.67%
PM (TTM) N/A
GM 38.01%
FCFM 4.46%
ROA(3y)-0.58%
ROA(5y)1.52%
ROE(3y)-6.47%
ROE(5y)1.48%
ROIC(3y)3.2%
ROIC(5y)4.54%
ROICexc(3y)3.57%
ROICexc(5y)5.33%
ROICexgc(3y)9.57%
ROICexgc(5y)12.38%
ROCE(3y)4.43%
ROCE(5y)6.16%
ROICexgc growth 3Y-30.34%
ROICexgc growth 5Y-21.96%
ROICexc growth 3Y-22.52%
ROICexc growth 5Y-26.32%
OM growth 3Y-25.59%
OM growth 5Y-17.42%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.94%
GM growth 5Y-2.16%
F-Score3
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF 22.91
Debt/EBITDA 6.3
Cap/Depr 44.73%
Cap/Sales 3.47%
Interest Coverage 4.42
Cash Conversion 51.39%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 1.05
Altman-Z 1.89
F-Score3
WACC7.05%
ROIC/WACC0.49
Cap/Depr(3y)49.31%
Cap/Depr(5y)63.51%
Cap/Sales(3y)5.12%
Cap/Sales(5y)5.45%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.37%
EPS 3Y-9.2%
EPS 5Y-4.21%
EPS Q2Q%-34.09%
EPS Next Y-7.17%
EPS Next 2Y0.96%
EPS Next 3Y3.75%
EPS Next 5Y6.87%
Revenue 1Y (TTM)-13.21%
Revenue growth 3Y-5.95%
Revenue growth 5Y-1.31%
Sales Q2Q%-29.14%
Revenue Next Year6.13%
Revenue Next 2Y5.12%
Revenue Next 3Y4.71%
Revenue Next 5Y5.61%
EBIT growth 1Y-21.12%
EBIT growth 3Y-30.01%
EBIT growth 5Y-18.5%
EBIT Next Year69.69%
EBIT Next 3Y22.35%
EBIT Next 5Y25.92%
FCF growth 1Y-44.58%
FCF growth 3Y-27.1%
FCF growth 5Y-16.46%
OCF growth 1Y-40.96%
OCF growth 3Y-22.88%
OCF growth 5Y-13.5%

BAXTER INTERNATIONAL INC / 1BAX.MI FAQ

What is the ChartMill fundamental rating of BAXTER INTERNATIONAL INC (1BAX.MI) stock?

ChartMill assigns a fundamental rating of 3 / 10 to 1BAX.MI.


Can you provide the valuation status for BAXTER INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to BAXTER INTERNATIONAL INC (1BAX.MI). This can be considered as Fairly Valued.


Can you provide the profitability details for BAXTER INTERNATIONAL INC?

BAXTER INTERNATIONAL INC (1BAX.MI) has a profitability rating of 2 / 10.


What is the valuation of BAXTER INTERNATIONAL INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BAXTER INTERNATIONAL INC (1BAX.MI) is 7.79 and the Price/Book (PB) ratio is 1.55.


Can you provide the dividend sustainability for 1BAX stock?

The dividend rating of BAXTER INTERNATIONAL INC (1BAX.MI) is 3 / 10 and the dividend payout ratio is -90.91%.